Dr Joseph Chervenak Discusses How Large Language Models Are Revolutionizing Reproductive Care
October 17th 2023Joseph Chervenak, MD, MBA, obstetrician and gynecologist, Montefiore Institute for Reproductive Medicine and Health, breaks down the benefits and challenges associated with implementing large language models such as ChatGPT into reproductive medicine and fertility care.
Patient, Provider Education and Payer Management Can Improve Biosimilar Uptake: Dr Bincy Abraham
October 15th 2023Biosimilars are becoming more common as more launch on the market in the United States, but patient and provider education can help speed uptake of these products, explained Bincy Abraham, MD, Houston Methodist – Weill Cornell.
Dr David Adamson Discusses How Professional Guidelines Impact Reproductive Care Outcomes
October 13th 2023David Adamson, MD, FRCSC, FACOG, FACS, reproductive endocrinologist, surgeon, founder and CEO of ARC Fertility, and past president of The American Society for Reproductive Medicine, discusses the importance of professional guidelines in reproductive medicine.
Dr Steven Deitelzweig: Identifying Patients With Atrial Fibrillation Using a Detection Device
October 10th 2023Steven Deitelzweig, MD, system chairman of hospital medicine at Ochsner Clinical School, professor of medicine at the University of Queensland, discusses key findings from a recent study on the accuracy of atrial fibrillation detection devices.
Avidity Biosciences Gains FDA Orphan Drug Designation for Patients With DMD
October 9th 2023Sarah Boyce, president and CEO at Avidity Biosciences, discusses her leading role at the company, as well as antibody oligonucleotide conjugate drug, AOC 1044, currently in development for Duchenne muscular dystrophy (DMD) with mutations amenable to exon 44 skipping (DMD44).
Mike Koroscik Discusses Population Health Reimbursement Models and Increased Lung Cancer Screening
October 7th 2023Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health and the Allina Health Cancer Institute, discusses the successes and challenges of a population health reimbursement model and gives advice for other health organizations considering a similar partnership within their practices.
Dr Afreen Idris Shariff on the Value of e-Consults for Endocrine Toxicities of ICIs
October 7th 2023Afreen Idris Shariff, MD, MBBS, director at Duke Endo-Oncology Program, Duke Endocrinology, Duke Cancer Institute, discusses how e-consults are addressing specific endocrine immune-related adverse events from immune checkpoint inhibitors (ICIs), reducing time to appointment, and lowering the need for hospitalization.
Dr Margaret Liang Discusses Key Initiatives in Financial Advocacy Programs for Patients With Cancer
October 6th 2023Margaret Liang, MD, MSHPM, gynecologic oncologist and program director for the gynecologic oncology fellowship program at Cedars-Sinai Cancer Center, discusses the Association of Community Cancer Centers' Financial Advocacy Services guidelines, which focus on providing financial support to patients with cancer.
Kathy Oubre Discusses Alternative Payment Models in Smaller Health Care Practices
October 6th 2023Kathy Oubre, MS, CEO of Pontchartrain Cancer Center, speaks on the unique perspectives and challenges smaller health care practices may face when entering into alternative payment models and shares key insights for addressing these issues.
Dr Olalekan Ajayi Previews Key Topics to Be Presented at the ACCC National Oncology Conference
October 3rd 2023Olalekan Ajayi, PharmD, MBA, 2023-2024 president of the Association of Community Cancer Centers (ACCC) and chief operating officer of Highlands Oncology Group, PA, reflects upon his role at ACCC and highlights key topics in oncology care and cancer research that will be presented at the National Oncology Conference.
Lisa Rometty Discusses Challenges, Opportunities in At-Home Phototherapy
September 27th 2023Lisa Rometty, CEO at Zerigo Health, discusses the challenges and opportunities for growth within the digital health landscape, as well as how Zerigo plans to collaborate with patients and payers to make sure digital health tools are accessible and affordable.
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.